Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-002227-96-SE
EUCTR2014-002227-96-SE
Active, not recruiting
Not Applicable

Inhibition of platelet aggregation after administration of three different ticagrelor loading dose formulations in patients with stable angina referred for coronary angiography - IPAAD-Tica

County Council of Östergötland0 sitesJuly 29, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsBrilique

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
County Council of Östergötland
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 29, 2014
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
County Council of Östergötland

Eligibility Criteria

Inclusion Criteria

  • •Patients with stable angina referred for coronary angiography
  • •Ability to provide informed consent
  • •Age 18 years or older
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 50
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 50

Exclusion Criteria

  • •Pregnacy or lactation, chronic therapy with ticagrelor, prasugrel, clopidogrel or ticlopidine, treatment with warfarin or NOAC in the last 4 days, active bleeding or increased risk of bleeding, history of gastrointestinal or geniourinary bleeding in the last 2 months, history of intracranial bleeding, major surgery in the last 4 weeks, severe anaemia or thrombocytopenia, severe liver or renal disease, increased risk of bradycardia, unable to chew tablet.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrelIschemic heart diseases with PIC
JPRN-UMIN000014161Kazuo Umemura Center for clinical research Hamamatsu University Hospital50
Active, not recruiting
Not Applicable
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABG
EUCTR2008-001135-35-CZThe Medicines Company220
Active, not recruiting
Not Applicable
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGE
EUCTR2008-001135-35-GBThe Medicines Company220
Active, not recruiting
Not Applicable
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGE
EUCTR2008-001135-35-NLThe Medicines Company220
Completed
Phase 2
Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trialplatelet inhibition10011082
NL-OMON34815Medicines Company50